Clinical Trial

Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis

Study acronym: NoVa
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The norepinephrine and vasopressin for rescue versus early vasopressin for vasopressor dependent sepsis (NoVa) is a phase 3, multicenter, open-label, randomized controlled trial comparing an early vasopressin initiation strategy versus norepinephrine plus vasopressin initiation only as a rescue strategy for hemodynamic management of critically ill patients with vasopressor dependent sepsis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-06-13; most recent amendment 2026-01-28.
Status change: Not Yet Recruiting → Recruiting 2024-10-10
Trial Details
NCT Number NCT06464510
Lead Sponsor Hospital do Coracao
Collaborators: Brazilian Research In Intensive Care Network, National Institute of Science and Technology (INCT) in Precision Intensive Care Medicine
Conditions Septic Shock
Enrollment 2,800 participants
Start Date 2024-11-21
Primary Completion 2027-08 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-30